medigraphic.com
ISSN 2221-2434 (Electronic)

2012, Number 1

<< Back Next >>

Finlay 2012; 2 (1)

The New England Journal of Medicine, CorSalud and Cardiovascular Disease

Moreno MFL

Language: Spanish
References: 14
Page: 6-7
PDF size: 77.03 Kb.


Text Extraction

No abstract.


REFERENCES

  1. Diaz MN, Frei B, Vita JA, Keaney JF. Antioxidants and atherosclerotic heart disease. N Engl J Med. 1997;337 (6):408-16.

  2. Knopp RH. Drug treatment of lipid disorders. N Engl J Med. 1999, 341(7):498-511.

  3. Ross R. Atherosclerosis – An inflammatory disease. N Engl J Med. 1999; 340(2):115-26.

  4. Nabel EG, Braunwald E. A tale of coronary artery disease and myocardial infarction. N Engl J Med. 2012;366(1):54-63.

  5. Moreno Martínez FL, Escobar Blanco A, Díaz López F, Alegret Rodríguez M, López-Bernal OJ, Aladro Miranda I, et al. Factores de riesgo coronario y riesgo cardiovascular en personas adultas de un área de salud de Rancho Veloz (Cuba). Clin Invest Arterioscl. 2008;20(4):151-61.

  6. Berry JD, Dyer A, Cai X, Garside DB, Ning H, Thomas A, et al. Lifetime Risks of Cardiovascular Disease. N Engl J Med. 2012;366(4):321-9.

  7. Smith SC, Allen J, Blair SN, Bonow RO, Brass LM, Fonarow GC, et al. AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update. Circulation. 2006;113(19):2363-72.

  8. Ting P, Chua TSJ, Wong A, Sim LL, Tan VWD, Koh TH. Trends in mortality from acute myocardial infarction in the Coronary Care Unit. Ann Acad Med Singapore. 2007;36(12):974-9.

  9. Di Mario C, Dudek D, Piscione F, Mielecki W, Savonitto S, Murena E, et al. Immediate angioplasty versus standard therapy with rescue angioplasty after thrombolysis in the Combined Abciximab REteplase Stent Study in Acute Myocardial Infarction (CARESS-in -AMI): an open, prospective, randomised, multicentre trial. Lancet. 2008;371(9612):559-68.

  10. Grüntzig AR, Senning A, Siegenthaler WE. Nonoperative dilation of coronary-artery stenosis: percutaneous transluminal coronary angioplasty. N Engl J Med. 1979;301(2):61-8.

  11. Doostzadeh J, Clark LN, Bezenek S, Pierson W, Sood PR, Sudhir K. Recent progress in percutaneous coronary intervention: evolution of the drug-eluting stents, focus on the XIENCE V drug-eluting stent. Coron Artery Dis. 2010;21(1):46-56.

  12. Farooq V, Gogas BD, Serruys PW. Restenosis: delineating the numerous causes of drug-eluting stent restenosis. Circ Cardiovasc Interv. 2011;4(2):195-205.

  13. Palacios IF. Intervenciones coronarias percutáneas en pacientes diabéticos. Rev Argent Cardiol[revista en Internet]. 2009[citado: 29 Ene 2012];77(6):[aprox. 32p.]. Disponible en: http://www.scielo.org.ar/ s c i e l o . p h p? s c r i p t = s c i _ a r t t e x t & p i d = S1850- 37482009000600013.

  14. Carro A. Factores de riesgo cardiovascular, una epidemia żprevenible? CorSalud [revista en Internet]. 2012[citado: 29 Ene 2012];4(1):[aprox. 10p.]. Disponible en: http://www.corsalud.sld.cu/pdf/2012/ v4n1a12/es/epidemia.pdf.




2020     |     www.medigraphic.com